Putnam Investments’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,176
Closed -$495K 1343
2016
Q4
$495K Sell
6,176
-300
-5% -$23.8K ﹤0.01% 1120
2016
Q3
$517K Buy
6,476
+200
+3% +$16.1K ﹤0.01% 1122
2016
Q2
$490K Buy
6,276
+21
+0.3% +$1.5K ﹤0.01% 1196
2016
Q1
$344K Sell
6,255
-231,226
-97% -$12.6M ﹤0.01% 1300
2015
Q4
$14.7M Buy
237,481
+143,777
+153% +$9.07M 0.03% 366
2015
Q3
$5.91M Buy
93,704
+87,204
+1,342% +$6.22M 0.01% 610
2015
Q2
$475K Sell
6,500
-71,817
-92% -$5.19M ﹤0.01% 1352
2015
Q1
$5.12M Sell
78,317
-219,629
-74% -$14.6M 0.01% 776
2014
Q4
$19.4M Sell
297,946
-1,876,642
-86% -$121M 0.04% 346
2014
Q3
$131M Sell
2,174,588
-1,056,650
-33% -$69M 0.28% 87
2014
Q2
$224M Buy
3,231,238
+147,354
+5% +$9.55M 0.48% 50
2014
Q1
$202M Buy
3,083,884
+347,623
+13% +$22.6M 0.46% 59
2013
Q4
$170M Buy
2,736,261
+944,348
+53% +$54.7M 0.41% 59
2013
Q3
$96.1M Buy
1,791,913
+65,802
+4% +$3.39M 0.26% 106
2013
Q2
$78.8M Buy
+1,726,111
New +$74.8M 0.23% 117

Other funds holding STJ

Putnam Investments's STJ Position: Q1 2017 in Review

Putnam Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,176 shares — an estimated $495K sold.

Putnam Investments first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $224M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Putnam Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Putnam Investments sold 6,176 St Jude Medical shares in Q1 2017, an estimated $495K.
  • Putnam Investments first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Putnam Investments's St Jude Medical position peaked at $224M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.